Impact of Dyspnea on Adults with Respiratory Symptoms Without a Defined Diagnosis.

Asthma COPD case-finding dyspnea

Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
04 Sep 2024
Historique:
received: 12 05 2024
revised: 22 07 2024
accepted: 30 07 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: aheadofprint

Résumé

We investigated dyspnea, its associated risk factors, and its impact on healthcare utilization, quality of life, and work productivity in adults with undiagnosed respiratory symptoms. What is the impact of dyspnea in adults with undiagnosed respiratory symptoms? This population-based study included 2857 adults who were experiencing respiratory symptoms. These individuals had not been previously diagnosed with any lung conditions and were recruited from 17 Canadian centers using random digit-dialing. Each participant underwent spirometry testing both before and after using a bronchodilator to determine if they met the diagnostic criteria for COPD, asthma, Preserved Ratio Impaired Spirometry (PRISm), or if their spirometry results were normal. An age-matched control group (n= 231) was similarly recruited using random-digit dialing. A dyspnea impact assessment score from 0 to 100 was produced using questions from the COPD Assessment Test and St. George's Respiratory Questionnaire. Individuals with PRISm (n=172) reported more impactful dyspnea (mean score 63.0, 95% CI: 59.5- 66.4) than those with undiagnosed asthma (n=265, mean score 56.6, 95% CI: 53.9-59.3) or undiagnosed COPD (n=330, mean score 57.5, 95% CI: 55.1-59.9). All groups reported significantly more impactful dyspnea compared to controls (mean score 13.8, 95% CI:11.8-15.7). Subject-specific risk factors including age, sex, BMI, smoking, and comorbidities explained 20.6% of the variation in dyspnea. An additional 12.4% of the variation was explained by disease classification and another 1.7% by the severity of lung function impairment assessed with spirometry. After adjusting for age, sex, and BMI, greater dyspnea impact was associated with increased healthcare utilization, lower quality of life, and reduced work productivity. In community-based adults with undiagnosed respiratory symptoms, those identified with PRISm experienced the greatest impact of dyspnea. Dyspnea imposes burdens on the healthcare system and is associated with impaired quality of life and work productivity.

Sections du résumé

BACKGROUND BACKGROUND
We investigated dyspnea, its associated risk factors, and its impact on healthcare utilization, quality of life, and work productivity in adults with undiagnosed respiratory symptoms.
RESEARCH QUESTION OBJECTIVE
What is the impact of dyspnea in adults with undiagnosed respiratory symptoms?
STUDY DESIGN AND METHODS METHODS
This population-based study included 2857 adults who were experiencing respiratory symptoms. These individuals had not been previously diagnosed with any lung conditions and were recruited from 17 Canadian centers using random digit-dialing. Each participant underwent spirometry testing both before and after using a bronchodilator to determine if they met the diagnostic criteria for COPD, asthma, Preserved Ratio Impaired Spirometry (PRISm), or if their spirometry results were normal. An age-matched control group (n= 231) was similarly recruited using random-digit dialing. A dyspnea impact assessment score from 0 to 100 was produced using questions from the COPD Assessment Test and St. George's Respiratory Questionnaire.
RESULTS RESULTS
Individuals with PRISm (n=172) reported more impactful dyspnea (mean score 63.0, 95% CI: 59.5- 66.4) than those with undiagnosed asthma (n=265, mean score 56.6, 95% CI: 53.9-59.3) or undiagnosed COPD (n=330, mean score 57.5, 95% CI: 55.1-59.9). All groups reported significantly more impactful dyspnea compared to controls (mean score 13.8, 95% CI:11.8-15.7). Subject-specific risk factors including age, sex, BMI, smoking, and comorbidities explained 20.6% of the variation in dyspnea. An additional 12.4% of the variation was explained by disease classification and another 1.7% by the severity of lung function impairment assessed with spirometry. After adjusting for age, sex, and BMI, greater dyspnea impact was associated with increased healthcare utilization, lower quality of life, and reduced work productivity.
INTERPRETATION CONCLUSIONS
In community-based adults with undiagnosed respiratory symptoms, those identified with PRISm experienced the greatest impact of dyspnea. Dyspnea imposes burdens on the healthcare system and is associated with impaired quality of life and work productivity.

Identifiants

pubmed: 39242078
pii: S0012-3692(24)05133-X
doi: 10.1016/j.chest.2024.07.183
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Jared Bierbrier (J)

The Ottawa Hospital Research Institute, University of Ottawa, Canada.

Emily Gerstein (E)

The Ottawa Hospital Research Institute, University of Ottawa, Canada.

G A Whitmore (GA)

Desautels Faculty of Management, McGill University, Canada.

Katherine L Vandemheen (KL)

The Ottawa Hospital Research Institute, University of Ottawa, Canada.

Celine Bergeron (C)

Department of Medicine, The University of British Columbia, Canada.

Louis-Philippe Boulet (LP)

Centre de recherche, Institut de cardiologie et de pneumologie de Québec. Université Laval, Canada.

Andreanne Cote (A)

Centre de recherche, Institut de cardiologie et de pneumologie de Québec. Université Laval, Canada.

Stephen K Field (SK)

Cumming School of Medicine, University of Calgary, Canada.

Erika Penz (E)

Department of Medicine, University of Saskatchewan, Canada.

R Andrew McIvor (RA)

Firestone Institute for Respiratory Health, McMaster University, Canada.

Catherine Lemière (C)

Department of Medicine, Université de Montreal, Canada.

Samir Gupta (S)

Department of Medicine and the Li Ka Shing Knowledge Institute of St. Michael's Hospital University of Toronto, Canada.

Paul Hernandez (P)

Department of Medicine, Dalhousie University, Canada.

Irvin Mayers (I)

Department of Medicine, University of Alberta, Canada.

Mohit Bhutani (M)

Department of Medicine, University of Alberta, Canada.

M Diane Lougheed (MD)

Department of Medicine, Queen's University, Canada.

Christopher J Licskai (CJ)

Department of Medicine, University of Western, Ontario, Canada.

Tanweer Azher (T)

Department of Medicine, Memorial University, Canada.

Nicole Ezer (N)

Department of Medicine, McGill University, Canada.

Martha Ainslie (M)

Department of Medicine, University of Manitoba, Canada.

Gonzalo G Alvarez (GG)

The Ottawa Hospital Research Institute, University of Ottawa, Canada.

Sunita Mulpuru (S)

The Ottawa Hospital Research Institute, University of Ottawa, Canada.

Shawn D Aaron (SD)

The Ottawa Hospital Research Institute, University of Ottawa, Canada. Electronic address: saaron@ohri.ca.

Classifications MeSH